Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and nonpulsatile left ventricular assist devices

Circulation: Heart Failure

Volumn 6, Issue 2, 2013, Pages 293-299

  Markham, David W ^a   Fu, Qi ^a,b   Palmer, M Dean ^b   Drazner, Mark H ^a   Meyer, Dan M ^a   Bethea, Brian T ^a   Hastings, Jeffrey L ^a,b   Fujimoto, Naoki ^a,b   Shibata, Shigeki ^a,b   Levine, Benjamin D ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

Author keywords

Assist device; Baroreceptors; Heart failure; Nonpulsatility; Pulsatility

Indexed keywords

ADRENALIN; CATECHOLAMINE; BIOLOGICAL MARKER; DOPAMINE; NORADRENALIN;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD TILTING; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN TISSUE; LEFT VENTRICULAR ASSIST DEVICE; MALE; MEAN ARTERIAL PRESSURE; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRIORITY JOURNAL; PULSATILE FLOW; STANDING; VASCULAR RESISTANCE; ADRENERGIC SYSTEM; ANALYSIS OF VARIANCE; ARTERIAL PRESSURE; BLOOD; BODY POSTURE; COMPARATIVE STUDY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; INNERVATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; PROSTHESIS; SKELETAL MUSCLE; SUPINE POSITION; TILT TABLE TEST; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANALYSIS OF VARIANCE; ARTERIAL PRESSURE; BAROREFLEX; BIOLOGICAL MARKERS; CARDIAC OUTPUT; DOPAMINE; EPINEPHRINE; FEMALE; HEART FAILURE; HEART RATE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NOREPINEPHRINE; POSTURE; PROSTHESIS DESIGN; PULSATILE FLOW; SUPINE POSITION; SYMPATHETIC NERVOUS SYSTEM; TEXAS; TILT-TABLE TEST; TIME FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

MLCS; MLOWN;

EID: 84877249172     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.969873     Document Type: Article

References (32)

1. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS; HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55:1826-1834.
2. Long JW, Kfoury AG, Slaughter MS, Silver M, Milano C, Rogers J, Delgado R, Frazier OH. Long-term destination therapy with the Heart- Mate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005;11:133-138.
3. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
4. Ambardekar AV, Walker JS, Walker LA, Cleveland JC Jr, Lowes BD, Buttrick PM. Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Fail. 2011;4:425-432.
5. Abboud FM, Heistad DD, Mark AL, Schmid PG. Reflex control of the peripheral circulation. Prog Cardiovasc Dis. 1976;18:371-403.
6. Chapleau MW, Hajduczok G, Abboud FM. New insights into the influence of pulsatile pressure on the arterial baroreceptor reflex. Clin Exp Hypertens A. 1988;10:179-191.
7. Chapleau MW, Hajduczok G, Abboud FM. Pulsatile activation of baroreceptors causes central facilitation of baroreflex. Am J Physiol. 1989;256(6 pt 2):H1735-H1741.
8. Laszlo G. Respiratory measurements of cardiac output: from elegant idea to useful test. J Appl Physiol. 2004;96:428-437.
9. Triebwasser JH, Johnson RL, Burpo RP, Campbell JC, Reardon WC, Blomqvist CG. Noninvasive determination of cardiac output by a modified acetylene rebreathing procedure utilizing mass spectrometer measurements. Aviat Space Environ Med. 1977;48:203-209.
10. Kallay MC, Hyde RW, Smith RJ, Rothbard RL, Schreiner BF. Cardiac output by rebreathing in patients with cardiopulmonary diseases. J Appl Physiol. 1987;63:201-210.
11. Sundlöf G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol (Lond). 1978;274:621-637.
12. Fu Q, Witkowski S, Levine BD. Vasoconstrictor reserve and sympathetic neural control of orthostasis. Circulation. 2004;110:2931-2937.
13. FA vdH, F B, AJ MitV, MA S. Determination of catecholamines in human plasma by high-performance liquid chromatography: Comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr. 1989;487:17-28.
14. Fu Q, Shook RP, Okazaki K, Hastings JL, Shibata S, Conner CL, Palmer MD, Levine BD. Vasomotor sympathetic neural control is maintained during sustained upright posture in humans. J Physiol (Lond). 2006;577(pt 2):679-687.
15. Chapleau MW, Abboud FM. Determinants of sensitization of carotid baroreceptors by pulsatile pressure in dogs. Circ Res. 1989;65:566-577.
16. Mccubbin JW, Green JH, Page IH. Baroceptor function in chronic renal hypertension. Circ Res. 1956;4:205-210.
17. Amir O, Radovancevic B, Delgado RM III, Kar B, Radovancevic R, Henderson M, Cohn WE, Smart FW. Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support. J Heart Lung Transplant. 2006;25:391-394.
18. Young CN, Fisher JP, Gallagher KM, Whaley-Connell A, Chaudhary K, Victor RG, Thomas GD, Fadel PJ. Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans. J Physiol (Lond). 2009;587(pt 20):4977-4986.
19. Klotz S, Burkhoff D, Garrelds IM, Boomsma F, Danser AH. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur Heart J. 2009;30:805-812.
20. Welp H, Rukosujew A, Tjan TD, Hoffmeier A, Kösek V, Scheld HH, Drees G. Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure. Thorac Cardiovasc Surg. 2010;58(suppl 2):S185-S188.
21. Ma X, Sigmund CD, Hingtgen SD, Tian X, Davisson RL, Abboud FM, Chapleau MW. Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice. Hypertension. 2004;43:312-316.
22. Kontak AC, Wang Z, Arbique D, Adams-Huet B, Auchus RJ, Nesbitt SD, Victor RG, Vongpatanasin W. Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism. J Clin Endocrinol Metab. 2010;95:4756-4761.
23. Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009;54:375-385.
24. Esler M. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol. 2010;108:227-237.
25. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33:1058-1066.
26. Notarius CF, Spaak J, Morris BL, Floras JS. Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure. J Card Fail. 2007;13:470-475.
27. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974-1979.
28. Miyagawa S, Sawa Y, Fukushima N, Nishimura M, Matsumiya G, Taketani S, Horiguchi K, Ohtake S, Matsuda H. Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support. J Heart Lung Transplant. 2001;20:1181-1187.
29. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, Ntalianis AS, Theodoropoulos SP, Yacoub MH, Nanas JN. Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging. 2010;3:64-70.
30. Birks EJ, George RS, Hedger M, Bahrami T, Wilton P, Bowles CT, Webb C, Bougard R, Amrani M, Yacoub MH, Dreyfus G, Khaghani A. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation. 2011;123:381-390.
31. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Sundareswaran KS, Farrar DJ, Slaughter MS; HeartMate II Clinical Investigators. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5:241-248.
32. Esler M, Kaye D. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev. 2000;5:17-25.